In addition, it was observed that therapy with disease-modifying antirheumatic drugs (DMARDs) modified the microbiome to its normal state in those patients who showed clinical improvement after treatment, which indicates that the information obtained from the microbiome It can also be used to determine if there is a response to treatment.
We hope that the association study of the metagenome of the oral and fecal microbiome is useful to promote the stratification of patients, predict the efficacy of drugs and explore new therapeutic targets Flekosteel, leading to the accurate diagnosis and treatment of rheumatoid arthritis, states the authors of the work.
No comments:
Post a Comment